Key Highlights: •MGC Pharma launches CannEpil® Appand provides...

Key Highlights:
•MGC Pharma launches CannEpil® Appand provides access to the International Library of Cannabinoids to medical professionals as part of its continuing collaboration with the Royal Melbourne Institute of Technology (RMIT)
•The CannEpil®App is designed to collect patient data, whilst under the supervision of a medicinal practitioner, with the goal of further evaluating the usage, dosage and efficacy of CannEpil® as a treatment
•The International Library of Cannabinoids has been developed as a world first centralised platform compiling and curating the diverse range of existing data on the therapeutic benefits of cannabinoids
•Launch of CannEpil® App and the International Library of Cannabinoids significantly strengthens MGC Pharma’s medicinal cannabis IP and allows it to remain at the forefront of cannabinoid innovation
•Data collection on this scale will provide comprehensive and transparent information on cannabinoid treatments, driving growth in the industry, facilitating higher adoption rates and allowing MXC to tailor future products and ensure their efficacy from early stages of development

Now just add a block-chain and it's a win/win.